| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.81B | +20.4% |
| Gross profit | ¥0.32B | — |
| Operating income | ¥-0.01B | — |
| Net income | ¥-0.01B | — |
| Gross margin | 39.7% | Net margin -1.2% |
| Revenue Q/Q | -21.6% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.49B | 60.3% |
| R&D | ¥0.09B | 11.0% |
| SG&A | ¥0.22B | 27.6% |
| Tax & other | ¥0.00B | 0.0% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
英科医疗 ・ 中科信息 ・ 电连技术 ・ 隆盛科技 ・ 英搏尔 ・ 朗新科技 ・ 海特生物 ・ 中石科技 ・ 艾德生物 ・ 智动力 ・ 赛意信息 ・ 创业黑马
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies